![Sahil Kirpekar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sahil Kirpekar
Chief Executive Officer at
Reunion Neuroscience, Inc.
Net worth: 523 831 $ as of 31/05/2026
Profile
Sahil V.
Kirpekar is currently President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. since 2026.
Formerly, served as Director at IntelGenx Technologies Corp.
from 2023 to 2024, Chief Business Officer at Atai Beckley NV from 2022 to 2025, and Head-Business Development at Otsuka Pharmaceutical Co., Ltd. Education includes graduate studies at the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.03% | 15/09/2025 | 1,15,636 ( 0.03% ) | 523 831 $ | 31/05/2026 |
Sahil Kirpekar active positions
| Companies | Position | Start |
|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Chief Executive Officer | 15/06/2026 |
Former positions of Sahil Kirpekar
| Companies | Position | End |
|---|---|---|
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | 02/04/2025 |
| INTELGENX TECHNOLOGIES CORP. | Director/Board Member | 17/05/2024 |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Corporate Officer/Principal | - |
Training of Sahil Kirpekar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
- Stock Market
- Insiders
- Sahil Kirpekar
Choose MarketScreener 
